Skip to main content
Journal cover image

82 COMBINATION EZETIMIBE/SIMVASTATIN + EXTENDED-RELEASE NIACIN THERAPY IMPROVES ATTAINMENT OF RECOMMENDED LDL-C, NON-HDL-C AND APOB LEVELS IN HYPERLIPIDEMIC PATIENTS

Publication ,  Conference
Fazio, S; Guyton, JR; Lin, J; Tomassini, JE; Shah, A; Tershakovec, AM
Published in: Atherosclerosis Supplements
June 2011

Duke Scholars

Published In

Atherosclerosis Supplements

DOI

ISSN

1567-5688

Publication Date

June 2011

Volume

12

Issue

1

Start / End Page

20 / 20

Publisher

Elsevier BV

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Fazio, S., Guyton, J. R., Lin, J., Tomassini, J. E., Shah, A., & Tershakovec, A. M. (2011). 82 COMBINATION EZETIMIBE/SIMVASTATIN + EXTENDED-RELEASE NIACIN THERAPY IMPROVES ATTAINMENT OF RECOMMENDED LDL-C, NON-HDL-C AND APOB LEVELS IN HYPERLIPIDEMIC PATIENTS. In Atherosclerosis Supplements (Vol. 12, pp. 20–20). Elsevier BV. https://doi.org/10.1016/s1567-5688(11)70083-6
Fazio, S., J. R. Guyton, J. Lin, J. E. Tomassini, A. Shah, and A. M. Tershakovec. “82 COMBINATION EZETIMIBE/SIMVASTATIN + EXTENDED-RELEASE NIACIN THERAPY IMPROVES ATTAINMENT OF RECOMMENDED LDL-C, NON-HDL-C AND APOB LEVELS IN HYPERLIPIDEMIC PATIENTS.” In Atherosclerosis Supplements, 12:20–20. Elsevier BV, 2011. https://doi.org/10.1016/s1567-5688(11)70083-6.
Fazio S, Guyton JR, Lin J, Tomassini JE, Shah A, Tershakovec AM. 82 COMBINATION EZETIMIBE/SIMVASTATIN + EXTENDED-RELEASE NIACIN THERAPY IMPROVES ATTAINMENT OF RECOMMENDED LDL-C, NON-HDL-C AND APOB LEVELS IN HYPERLIPIDEMIC PATIENTS. In: Atherosclerosis Supplements. Elsevier BV; 2011. p. 20–20.
Fazio, S., et al. “82 COMBINATION EZETIMIBE/SIMVASTATIN + EXTENDED-RELEASE NIACIN THERAPY IMPROVES ATTAINMENT OF RECOMMENDED LDL-C, NON-HDL-C AND APOB LEVELS IN HYPERLIPIDEMIC PATIENTS.” Atherosclerosis Supplements, vol. 12, no. 1, Elsevier BV, 2011, pp. 20–20. Crossref, doi:10.1016/s1567-5688(11)70083-6.
Fazio S, Guyton JR, Lin J, Tomassini JE, Shah A, Tershakovec AM. 82 COMBINATION EZETIMIBE/SIMVASTATIN + EXTENDED-RELEASE NIACIN THERAPY IMPROVES ATTAINMENT OF RECOMMENDED LDL-C, NON-HDL-C AND APOB LEVELS IN HYPERLIPIDEMIC PATIENTS. Atherosclerosis Supplements. Elsevier BV; 2011. p. 20–20.
Journal cover image

Published In

Atherosclerosis Supplements

DOI

ISSN

1567-5688

Publication Date

June 2011

Volume

12

Issue

1

Start / End Page

20 / 20

Publisher

Elsevier BV

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology